US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist
  • 8.520
  • +0.050+0.59%
Close Feb 14 16:00 ET
  • 8.452
  • -0.068-0.79%
Post 20:01 ET
724.75MMarket Cap-15.49P/E (TTM)

Anavex Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-65.62%-12.12M
-10.89%-30.81M
-13.83%-6.66M
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
Net income from continuing operations
-40.47%-12.11M
9.48%-43M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
33.53%-8.62M
0.99%-47.51M
29.00%-10.15M
8.79%-11.28M
-25.57%-13.11M
Other non cash items
----
----
----
----
----
----
--845K
--0
--0
----
Change In working capital
-110.18%-2.06M
9.86%2.75M
160.36%2.89M
2,027.20%4.61M
-1,809.64%-3.76M
-153.63%-982K
-53.27%2.51M
-73.60%1.11M
-118.03%-239K
94.59%-197K
-Change in receivables
87.14%-108K
-46.28%260K
-34.25%-729K
-19.71%2.07M
63.30%-236K
6.87%-840K
-91.86%484K
-116.13%-543K
2,931.29%2.57M
41.38%-643K
-Change in prepaid assets
313.59%220K
7.02%-278K
-26.44%128K
84.52%286K
-80.12%-589K
65.78%-103K
-30,000.00%-299K
61.99%174K
5,766.77%155K
-276.97%-327K
-Change in payables and accrued expense
-5,446.15%-2.16M
54.03%2.85M
141.11%3.57M
176.03%2.26M
-479.95%-2.94M
-101.52%-39K
416.27%1.85M
102.65%1.48M
-309.84%-2.97M
131.45%773K
-Change in other working capital
---13K
-115.86%-75K
----
----
----
----
--473K
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
-65.62%-12.12M
-10.89%-30.81M
-13.83%-6.66M
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
1,100.00%708K
-59.61%11.98M
-95.67%89K
-49.46%4.55M
-60.31%7.28M
-77.13%59K
39.29%29.65M
83,341.56%2.06M
30.28%9M
54.90%18.33M
Net common stock issuance
----
-59.52%11.28M
--0
-51.89%4.11M
----
----
32.83%27.88M
41,554.98%1.19M
29.65%8.53M
----
Proceeds from stock option exercised by employees
1,100.00%708K
-61.09%691K
-89.75%89K
-5.33%444K
-45.30%99K
-77.13%59K
75.84%1.78M
456,942.11%868K
-8.62%469K
46.65%181K
Cash from discontinued financing activities
Financing cash flow
1,100.00%708K
-59.61%11.98M
-95.67%89K
-49.46%4.55M
-60.31%7.28M
-77.13%59K
39.29%29.65M
83,341.56%2.06M
30.28%9M
54.90%18.33M
Net cash flow
Beginning cash position
-12.47%132.19M
1.25%151.02M
-10.37%138.76M
-9.18%139.39M
0.10%143.77M
1.25%151.02M
-1.94%149.16M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
Current changes in cash
-57.21%-11.41M
-1,109.49%-18.84M
-73.19%-6.57M
-146.67%-630K
-144.48%-4.38M
-31.12%-7.26M
163.25%1.87M
6.15%-3.79M
1,042.71%1.35M
348.27%9.85M
End cash Position
-15.99%120.78M
-12.47%132.19M
-12.47%132.19M
-10.37%138.76M
-9.18%139.39M
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
Free cash flow
-65.62%-12.12M
-10.89%-30.81M
-13.83%-6.66M
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -65.62%-12.12M-10.89%-30.81M-13.83%-6.66M32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M
Net income from continuing operations -40.47%-12.11M9.48%-43M-14.53%-11.62M-8.28%-12.21M19.54%-10.55M33.53%-8.62M0.99%-47.51M29.00%-10.15M8.79%-11.28M-25.57%-13.11M
Other non cash items --------------------------845K--0--0----
Change In working capital -110.18%-2.06M9.86%2.75M160.36%2.89M2,027.20%4.61M-1,809.64%-3.76M-153.63%-982K-53.27%2.51M-73.60%1.11M-118.03%-239K94.59%-197K
-Change in receivables 87.14%-108K-46.28%260K-34.25%-729K-19.71%2.07M63.30%-236K6.87%-840K-91.86%484K-116.13%-543K2,931.29%2.57M41.38%-643K
-Change in prepaid assets 313.59%220K7.02%-278K-26.44%128K84.52%286K-80.12%-589K65.78%-103K-30,000.00%-299K61.99%174K5,766.77%155K-276.97%-327K
-Change in payables and accrued expense -5,446.15%-2.16M54.03%2.85M141.11%3.57M176.03%2.26M-479.95%-2.94M-101.52%-39K416.27%1.85M102.65%1.48M-309.84%-2.97M131.45%773K
-Change in other working capital ---13K-115.86%-75K------------------473K--0--0--0
Cash from discontinued investing activities
Operating cash flow -65.62%-12.12M-10.89%-30.81M-13.83%-6.66M32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 1,100.00%708K-59.61%11.98M-95.67%89K-49.46%4.55M-60.31%7.28M-77.13%59K39.29%29.65M83,341.56%2.06M30.28%9M54.90%18.33M
Net common stock issuance -----59.52%11.28M--0-51.89%4.11M--------32.83%27.88M41,554.98%1.19M29.65%8.53M----
Proceeds from stock option exercised by employees 1,100.00%708K-61.09%691K-89.75%89K-5.33%444K-45.30%99K-77.13%59K75.84%1.78M456,942.11%868K-8.62%469K46.65%181K
Cash from discontinued financing activities
Financing cash flow 1,100.00%708K-59.61%11.98M-95.67%89K-49.46%4.55M-60.31%7.28M-77.13%59K39.29%29.65M83,341.56%2.06M30.28%9M54.90%18.33M
Net cash flow
Beginning cash position -12.47%132.19M1.25%151.02M-10.37%138.76M-9.18%139.39M0.10%143.77M1.25%151.02M-1.94%149.16M1.06%154.82M0.08%153.47M-4.98%143.62M
Current changes in cash -57.21%-11.41M-1,109.49%-18.84M-73.19%-6.57M-146.67%-630K-144.48%-4.38M-31.12%-7.26M163.25%1.87M6.15%-3.79M1,042.71%1.35M348.27%9.85M
End cash Position -15.99%120.78M-12.47%132.19M-12.47%132.19M-10.37%138.76M-9.18%139.39M0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M
Free cash flow -65.62%-12.12M-10.89%-30.81M-13.83%-6.66M32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+4.45%
Strategy
MSTR
+3.94%
NVIDIA
NVDA
+2.63%
Vale SA
VALE
+1.99%
KB Home
KBH
+1.28%

Unlock the Full List